Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2020.08.26

ACS Green Chemistry Institute Pharmaceutical Roundtable

Sai Life Sciences joins the ACS Green Chemistry Institute Pharmaceutical Roundtable

Sai Life Sciences today announced its induction to the ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS-GCIPR) as an ‘Associate Member’. The company has been committed to increasing the adoption of Green Chemistry principles in its process development and instituted its inaugural ‘Green Chemistry Awards’ last year, to recognize and celebrate teams that make notable contributions towards greener processes. Joining the ACS-GCIPR will allow the company to interact with large pharma and other CDMOs to further share and develop best practices in Green chemistry and sustainability

Welcoming Sai Life Sciences into its fold, an ACS-GCIPR spokesperson said, “The ACS GCI Roundtable is delighted to welcome Sai Life Sciences into its membership. As one of a few CDMO companies in our membership, their enthusiasm in catalysing the integration of green chemistry and engineering in the pharmaceutical industry is another heartening sign that adoption of Green Chemistry principles is indeed gaining momentum. We look forward to their active participation in the important work of the roundtable.”

Established in 2005 by the American Chemical Society’s Green Chemistry Institute, the Pharmaceutical Roundtable’s activities are driven by the shared belief that green chemistry and engineering is imperative for business and environmental sustainability. Its member companies come together to catalyse innovative approaches to improving process efficiency and product quality through green chemistry and engineering.

Over the past 18 months, Sai Life Sciences has made several enhancements to its HSE practices as part of the org-wide transformation initiative, Sai Nxt. Earlier this year, it became the first India-headquartered company to join the PSCI membership. The company also received 5-Star rating for Excellence in EHS Practices at the Confederation of Indian Industry (CII) South awards 2019. It operates a Zero Liquid Discharge cGMP manufacturing site in Bidar, India and has achieved zero waste to landfill.

Share article

More News

2025.08.20

Sai Life Sciences secures SBTi validation for near-term climate targets

Sai Life Sciences Limited, an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse gas (GHG) emissions have been validated by the Science Based Targets initiative (SBTi)—a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis. […]
Read more

2025.08.20

Sai Life Sciences featured in Drug Discovery & Development on trends shaping drug discovery

Sai Life Sciences was recently featured in Drug Discovery & Development, where Dr Maneesh Pingle, Executive Vice President and Head of Discovery Services, shared insights on the emerging trends in pharma sector. A key focus was the impact of GLP 1 agonists in accelerating peptide drug discovery. Dr. Pingle explained how the success of these […]
Read more

2025.08.13

Peptide Science & Beyond: Masterclass & Fireside Chat with IISc Professor, Dr. Jayanta Chatterjee

Sai Life Sciences recently hosted Dr. Jayanta Chatterjee, Associate Professor at the Indian Institute of Science (IISc), Bangalore, for two enriching sessions at its campus. The first was the Masterclass Lecture Series, where Dr. Chatterjee addressed a group of scientists at Sai Life Sciences on “Our Adventures in the de novo Design of Helical Macrocyclic […]
Read more

2025.08.13

From vendor to vanguard: Reimagining India’s role in global life sciences

In a recent article published in ET Edge titled, ‘From Vendor to Vanguard: Reimagining India’s Role in Global Life Sciences,’ Krishna Kanumuri, MD & CEO, Sai Life Sciences, highlighted India’s rapidly unfolding transformation from a vendor to an innovation leader in the global life sciences ecosystem.You can read the full article here: From vendor to vanguard: […]
Read more

2025.08.08

Sai Life Sciences Limited Reports Revenue growth of 77% YoY

Q1FY26 Revenue at ₹496 Cr; EBITDA at ₹125 Cr; Net Profit at ₹60 Cr. Hyderabad, August 08, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research, Development and Manufacturing Organization (CRDMO) announced its financial results for the first quarter of Fiscal year 2026. Financial Performance: Particulars (₹ crores) Q1FY26 […]
Read more